IP Library › Assignment 023720/0976
Patent Assignment
Reel/Frame 023720/0976

Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc.

Recorded: 2010-01-04 Pages: 7
Assignor
ESBATECH AG
Executed: 2009-10-13
Assignee
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
WAGISTRASSE 21, SCHLIEREN, 8952, SWITZERLAND
Covered Properties (12)
Screening System
Patent: 6,821,728 →
Application: 09/720,106 →
Intrabodies with Defined Framework That Is Stable in a Reducing Environment and Applications Thereof
Patent: 7,258,985 →
Application: 09/750,424 →
Publication: US 2001/0024831
Intrabodies with Defined Framework That Is Stable in a Reducing Environment and Applications Thereof
Patent: 7,258,986 →
Application: 10/169,179 →
Publication: US 2003/0096306
Immunoglobulin Frameworks Which Demonstrate Enhanced Stability in the Intracellular Environment and Methods of Identifying Same
Patent: 8,853,362 →
Application: 10/515,241 →
Publication: US 2006/0035320
Yeast-Based Method for Detecting Interactions Between Two Test Proteins in an Oxidizing Environment
Application: 10/515,249 →
Publication: US 2006/0019238
Method for the Construction of Randomized Gene Sequence Libraries in Cells
Patent: 7,833,703 →
Application: 10/552,219 →
Publication: US 2007/0298466
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
Application: 11/894,097 →
Publication: US 2008/0233110
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,067,547 →
Application: 11/916,793 →
Publication: US 2009/0263382
Methods of Modifying Antibodies, and Modified Antibodies with Improved Functional Properties
Application: 12/145,600 →
Publication: US 2009/0074780
Sequence Based Engineering and Optimization of Single Chain Antibodies
Patent: 9,908,945 →
Application: 12/145,749 →
Publication: US 2009/0028848
Scfv Antibodies Which Pass Epithelial and/or Endothelial Layers
Patent: 8,936,785 →
Application: 12/307,875 →
Publication: US 2009/0311251
Sequence Based Engineering and Optimization of Single Chain Antibodies
Patent: 8,280,711 →
Application: 12/530,756 →
Publication: US 2010/0137150
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 26, 2001
From: ESCHER, DOMINIK; BARBERIS, ALCIDE
To: UNIVERSITAT ZURICH
Reel/Frame 011652/0392 →
Assignment of Assignor's Interest Apr 16, 2001
From: AUF DER MAUR, ADRIAN; BARBERIS, ALCIDE; ESCHER, DOMINIK
To: ESBATECH AG
Reel/Frame 011702/0824 →
Assignment of Assignor's Interest Mar 5, 2002
From: ZURICH, UNIVERSITAT
To: ESBATECH AG
Reel/Frame 012666/0380 →
Assignment of Assignor's Interest Sep 23, 2002
From: AUF DER MAUR, ADRIAN; BARBERIS, ALCIDE; ESCHER, DOMINIK
To: ESBATECH AG
Reel/Frame 013321/0409 →
Assignment of Assignor's Interest Mar 6, 2003
From: UNIVERSITAT ZURICH
To: ESBATECH AG
Reel/Frame 013811/0016 →
Assignment of Assignor's Interest Feb 10, 2005
From: URECH, DAVID M.; LICHTLEN, PETER; BARBERIS, ALCIDE
To: ESBATECH AG
Reel/Frame 015694/0645 →
Assignment of Assignor's Interest Mar 16, 2005
From: TISSOT, KATHRIN; EWERT, STEFAN; MAUR, ADRIAN AUF DER; BARBERIS, ALCIDE
To: ESBATECH AG
Reel/Frame 015910/0204 →
Assignment of Assignor's Interest Jun 27, 2006
From: SCHARER-BRODBECK, CLAUDIA
To: ESBATECH AG
Reel/Frame 017849/0996 →
Assignment of Assignor's Interest Jun 2, 2008
From: BARBERIS, ALCIDE; URECH, DAVID M.; LICHTLEN, PETER; AUF DER MAUR, ADRIAN
To: ESBATECH AG
Reel/Frame 021027/0070 →
Assignment of Assignor's Interest Dec 11, 2008
From: URECH, DAVID; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 021964/0412 →
Assignment of Assignor's Interest Feb 11, 2009
From: URECH, DAVID; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 022239/0773 →
Assignment of Assignor's Interest Jul 22, 2009
From: AUF DER MAUR, ADRIAN; BARBERIS, ALCIDE; URECH, DAVID M; LICHTLEN, PETER
To: ESBATECH AG
Reel/Frame 022987/0889 →
Assignment of Assignor's Interest Oct 8, 2009
From: URECH, DAVID M; BORRAS, LEONARDO
To: ESBATECH AG
Reel/Frame 023345/0456 →
Change of Name Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Assignment of Assignor's Interest Dec 11, 2009
From: ESBATECH AG
To: UNIVERSITAT ZURICH; DELENEX THERAPEUTICS AG
Reel/Frame 023639/0199 →
Change of Business Address Jun 8, 2010
From: DELENEX THERAPEUTICS AG
To: DELENEX THERAPEUTICS AG
Reel/Frame 024492/0670 →
Assignment of Assignor's Interest Aug 23, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 046677/0476 →
Assignment of Assignor's Interest Dec 13, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 047768/0136 →
Assignment of Assignor's Interest Dec 13, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 047768/0304 →
Assignment of Assignor's Interest Nov 8, 2019
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 050969/0094 →
Assignment of Assignor's Interest Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
Security Interest Jul 7, 2021
From: CELL MEDICA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056782/0954 →
Assignment of Assignor's Interest Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →
Assignment of Assignor's Interest Jan 26, 2024
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 066375/0028 →
Assignment of Assignor's Interest Jan 26, 2024
From: ESBATECH, A NOVARTIS COMPANY LLC
To: NOVARTIS AG
Reel/Frame 066375/0189 →